CSL NEW ZEALAND ALBUMEX 4 human albumin 40g/L 50mL injection solution vial Australia - English - Department of Health (Therapeutic Goods Administration)

csl new zealand albumex 4 human albumin 40g/l 50ml injection solution vial

csl behring australia pty ltd - albumin, quantity: 40 g/l - injection, solution - excipient ingredients: octanoate; sodium; chloride - 1. management of hypovolaemia/shock - albumex 4 may be used to help to maintain plasma volume. note that other fluids may be needed in the course of treatment. 2. cardiopulmonary bypass - albumex 4 may be used for priming the pump for cardiopulmonary bypass surgery. it may also be used in the management of hypovolaemia following cardiopulmonary bypass surgery. 3. plasma exchange - albumex 4 may be used in plasma exchange.

CSL NEW ZEALAND ALBUMEX 4 human albumin 40g/L 500mL injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

csl new zealand albumex 4 human albumin 40g/l 500ml injection vial

csl behring australia pty ltd - albumin, quantity: 40 g/l - injection, solution - excipient ingredients: sodium; chloride; octanoate - 1. management of hypovolaemia/shock - albumex 4 may be used to help maintain plasma volume. note that other fluids may be needed in the course of treatment. 2. cardiopulmonary bypass - albumex 4 may be used for priming the pump for cardiopulmonary bypass surgery. it may be also be used in the management of hypordaemia following cardiopulmonary bypass surgery. 3. plasma exchange - albumex 4 may be used in plasma exchange.

"TBSF" (20%) Human Albumin Solution Australia - English - Department of Health (Therapeutic Goods Administration)

"tbsf" (20%) human albumin solution

csl behring australia pty ltd - albumin, quantity: 200 g/l - injection, solution - excipient ingredients: octanoate; sodium - hypoproteinaemia in the acutely ill patient tbsf (20%) human albumin solution is administered when there are existing or anticipated clinical problems or complications from reduced oncotic pressure, and/or as an adjunct to diuretic therapy. shock. tbsf (20%) human albumin solution may be used for the resuscitation of patients in shock due to acute loss of blood or plasma, but 4 - 5% human albumin is preferred when available. burns. extensive burns are followed by sequential shifts in the distribution of body water, salt and proteins resulting in hypovolaemic shock and circulatory failure.

Human Albumin 20% Behring (Low Salt) 0.002 Solution for Intravenous Infusion Philippines - English - FDA (Food And Drug Administration)

human albumin 20% behring (low salt) 0.002 solution for intravenous infusion

zuellig pharma corporation; distributor: zuellig pharma corporation - human albumin - solution for intravenous infusion - 0.002

ALBUNATE 5 Human Albumin 50 g/L (5% w/v) 500 mL solution for intravenous infusion vial Australia - English - Department of Health (Therapeutic Goods Administration)

albunate 5 human albumin 50 g/l (5% w/v) 500 ml solution for intravenous infusion vial

csl behring australia pty ltd - albumin, quantity: 25 g - injection, intravenous infusion - excipient ingredients: water for injections; sodium acetyltryptophanate; sodium chloride; sodium octanoate - restoration and maintenance of circulating blood volume where volume deficiency has been demonstrated and use of a colloid is appropriate. the choice of albumin rather than artificial colloid will depend on the clinical situation of the individual patient.

ALBUNATE 5 Human Albumin 50 g/L (5% w/v) 250 mL solution for intravenous infusion vial Australia - English - Department of Health (Therapeutic Goods Administration)

albunate 5 human albumin 50 g/l (5% w/v) 250 ml solution for intravenous infusion vial

csl behring australia pty ltd - albumin, quantity: 12.5 g - injection, intravenous infusion - excipient ingredients: sodium acetyltryptophanate; sodium octanoate; water for injections; sodium chloride - restoration and maintenance of circulating blood volume where volume deficiency has been demonstrated and use of a colloid is appropriate. the choice of albumin rather than artificial colloid will depend on the clinical situation of the individual patient.

ALBUNATE 25 Human Albumin 250 g/L (25% w/v) 50 mL solution for intravenous infusion vial Australia - English - Department of Health (Therapeutic Goods Administration)

albunate 25 human albumin 250 g/l (25% w/v) 50 ml solution for intravenous infusion vial

csl behring australia pty ltd - albumin, quantity: 12.5 g - injection, intravenous infusion - excipient ingredients: sodium chloride; sodium acetyltryptophanate; sodium octanoate; water for injections - restoration and maintenance of circulating blood volume where volume deficiency has been demonstrated and use of a colloid is appropriate. the choice of albumin rather than artificial colloid will depend on the clinical situation of the individual patient.

ALBUNATE 25 Human Albumin 250 g/L (25% w/v) 100 mL solution for intravenous infusion vial Australia - English - Department of Health (Therapeutic Goods Administration)

albunate 25 human albumin 250 g/l (25% w/v) 100 ml solution for intravenous infusion vial

csl behring australia pty ltd - albumin, quantity: 25 g - injection, intravenous infusion - excipient ingredients: sodium chloride; sodium acetyltryptophanate; water for injections; sodium octanoate - restoration and maintenance of circulating blood volume where volume deficiency has been demonstrated and use of a colloid is appropriate. the choice of albumin rather than artificial colloid will depend on the clinical situation of the individual patient.

Human Albumin 20% Behring (Low Salt) 0.2 Solution for Intravenous Infusion Philippines - English - FDA (Food And Drug Administration)

human albumin 20% behring (low salt) 0.2 solution for intravenous infusion

zuellig pharma corporation - human albumin - solution for intravenous infusion - 0.2

CSL NZ Alburex 5 NZ human albumin 50 g/L (5% w/v) solution for intravenous infusion vial Australia - English - Department of Health (Therapeutic Goods Administration)

csl nz alburex 5 nz human albumin 50 g/l (5% w/v) solution for intravenous infusion vial

csl behring australia pty ltd - albumin, quantity: 50 g/l - injection, intravenous infusion - excipient ingredients: n-acetyl-dl-tryptophan; sodium octanoate; sodium chloride; water for injections - restoration and maintenance of circulating blood volume where volume deficiency has been demonstrated and use of colloid is appropriate. the choice of albumin rather than artificial colloid will depend on the clinical situation of the individual patient.